Cargando…
Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
Alzheimer’s disease is a neurodegenerative disorder accounting for more than 50% of cases of dementia. Diagnosis of Alzheimer’s disease relies on cognitive tests and analysis of amyloid beta, protein tau, and hyperphosphorylated tau in cerebrospinal fluid. Although these markers provide relatively h...
Autores principales: | Khoonsari, Payam Emami, Häggmark, Anna, Lönnberg, Maria, Mikus, Maria, Kilander, Lena, Lannfelt, Lars, Bergquist, Jonas, Ingelsson, Martin, Nilsson, Peter, Kultima, Kim, Shevchenko, Ganna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780771/ https://www.ncbi.nlm.nih.gov/pubmed/26950848 http://dx.doi.org/10.1371/journal.pone.0150672 |
Ejemplares similares
-
Improved Differential Diagnosis of Alzheimer’s Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers
por: Khoonsari, Payam Emami, et al.
Publicado: (2019) -
Increased Release of Apolipoprotein E in Extracellular Vesicles Following Amyloid-β Protofibril Exposure of Neuroglial Co-Cultures
por: Nikitidou, Elisabeth, et al.
Publicado: (2017) -
High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer’s disease
por: Degerman Gunnarsson, Malin, et al.
Publicado: (2016) -
Metabolic drift in the aging nervous system is reflected in human cerebrospinal fluid
por: Peters, Kristian, et al.
Publicado: (2021) -
CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease
por: Remnestål, Julia, et al.
Publicado: (2016)